Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.

Meir Medical Center62 enrolled

Overview

To evaluate changes in endothelial cell count after pterygium surgery with mitomycin C (MMC) 0.02%

To evaluate the change in endothelial cell count in patients after pterygium surgery with mitomycin C (MMC) 0.02% for 2 minutes in 2 groups. * The control group: application of MMC after excision of the body of the pterygium without the head * The study group: application of MMC after excision of the body and the head of the pterygium

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

Conditions

Pterygium

Interventions

Mitomycin C 0.02%DRUG

Pterygium excision with application of mitomycin C

Pterygium surgeryPROCEDURE

Two different procedures- excision of the head and the body and excision of the head only

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Males/females \>18 Years old * Pterygium with indication to operate * Subjects that are able to sign an informed consent Exclusion Criteria: * Recurrent Pterygium/suspected tumor lesion * Patients with endothelial cell diseases * Patients after anterior segment surgery * Patients with low compliance * Patients without judgment ability * Pregnancy * Patients participated in another survey

Locations (2)

Sackler school of medicine

Tel Aviv, Israel, Israel

Meir medical centre

Kfar Saba, Israel

Outcomes

Primary Outcomes

Endothelial cell count

Time frame: 3 months after surgery

Central Contacts

Fani Segev, MD

CONTACT

+792526995044 fsegev@netvision.net.il

Leena Asalee, MD

CONTACT

+972543031396 leenaasalee@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.